OSPE - Drug mechanisms of action Flashcards
Salbutamol
Agonist which causes adenylyl cyclase to increase cAMP resulting in decreased intracellular calcium ion concentration. Resulting in smooth muscle vasodilation and bronchodilation
Nifedipine
Channel Blocker
Inhibits the influx of Ca2+ in smooth muscle cells, decreasing vasoconstriction
Enalapril
Competitively inhibits ACE which prevents Angiotensin I conversion to Angiotensin II and lowers levels of angiotensin II which lowers vasoconstriction.
Simvastatin
Competitive inhibitor of HMG-CoA reductase, the enzyme catalysing the rate-limiting step of cholesterol synthesis, which decreases hepatic cholesterol concentrations.
Aspirin
Analgesic, antipyretic, and anti-inflammatory effects due to direct and irreversible inhibition of COX-1 and COX-2 leading to decreased formation of the precursors of prostaglandins and thromboxanes from arachidonic acid.
Inhibition of platelet aggregation caused by irreversible acetylation and inactivation of platelet COX, which blocks the formation of the aggregating agent thromboxane A2.
Fluoxetine
Inhibitor
Increase serotonin stimulation of somatodendritic and terminal 5HT receptors
Metoprolol
Prevents binding of norepinephrine to beta 1-adrenergic receptors in cardiac myocytes
Imatinib
Protein-tyrosine kinase inhibitor that inhibits proliferation and induces apoptosis in Bcr-Abl leukemic cells from Philadelphia chromosome positive chronic myeloid leukemia (CML) and as such is an antineoplastic agent.
Fentanyl
mu opioid receptor agonist causing decreased Ca2+ influx which results in decreased repolarization time and thus decreased action potential duration.
Rituximab
Monoclonal antibody
Binds to the antigen on B lymphocytes, recruits antibodies and complements to mediate cell killing
Diazepam
Increases chloride ion influx across the chloride ion channel pore at the centre of the GABAa subunit which hyperpolarizes the neuron’s membrane potential leading to a greater difference between resting potential and threshold.
Sildenafil
Blocks the degredation of cGMP which leads to vasodilation of smooth muscle
Clopidogrel
Inhibits ADP-induced platelet aggregation via irreversible inhibition of the P2Y12 subtype of ADP receptors.
Ranitidine
Competitive inhibition of H2 receptors on parietal cells leads to supression of gastric acid secretion.
Vancomycin
Prevents incorporation of NAM and NAG peptides into the peptidoglycan matrix, inhibiting cell wall synthesis